VEGF GENE POLYMORPHISM IN COMPLICATED INFECTIVE ENDOCARDITIS

被引:0
作者
Samoylenko, E. S. [1 ,2 ]
Kolesnikova, N., V [1 ]
Baklay, V., I [3 ]
Maydannikova, E. Yu [2 ]
Omelchenko, E., V [2 ]
机构
[1] Kuban State Med Univ, Mitrofana Sedina Str 4, Krasnodar 350063, Russia
[2] Ochapovsky Reg Clin Hosp 1, Sci Res Inst, Krasnodar, Russia
[3] Specialized Clin Infect Dis Hosp, Krasnodar, Russia
来源
INFEKTSIYA I IMMUNITET | 2022年 / 12卷 / 05期
关键词
infective endocarditis; VEGF; SNP; pathogenesis; diagnosis; thromboembolic complications; ENDOTHELIAL GROWTH-FACTOR; EXPRESSION; DISEASE; RISK;
D O I
10.15789/2220-7619-VGP-1877
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Introduction. Infective endocarditis (IE) is a bacterial disease with frequent pathogen localization on the heart valve apparatus. IE is characterized by rapid development of heart failure and frequent thromboembolic complications (TEC). IE features are accounted for by foreign pathogen nature and state of human immune system (IS). The imbalanced IS in infective endocarditis is manifested by impaired cytokine-mediated interactions. This confirms the rationality of studying cytokines to advance understanding of the pathogenesis for various conditions. Most cytokine genes are characterized by polymorphism and existing isoforms underlying disease predisposition. Genetic polymorphism of vascular endothelial growth factor - A (VEGF-A) plays an important role in the induction of vasculogenesis and angiogenesis. The pathogenetic VEGF role in IE has not been thoroughly studied. Research objective - analysis of polymorphic nucleotide sequence variants in the vascular endothelial growth factor gene, taking into account a relation with its serum concentration in patients with infective endocarditis. Materials and methods. 86 patients treated with verified diagnosis of infective endocarditis at the Scientific Research Institute - "Regional Clinical Hospital No. 1" of Krasnodar were divided into two clinical groups in accordance with the IE course: Group 1 - IE with TEC (n = 44), group 2 - IE without TEC (n = 42), and the control group consisted of 20 apparently healthy individuals. The concentration of serum VEGF-A (pg/mL) was measured by ELISA on day 1 of hospitalization. Genomic DNA was isolated from whole blood leukocytes and used to determine the frequency of genotypes of VEGF gene polymorphic variants. Results. Significant differences in the frequency distribution of VEGF-rs2010963 genotypes between patients with infective endocarditis and control group were revealed: G/G (OR = 0.25; p = 0.012) and G/C (OR = 4.28; p = 0.022), as well as differences between VEGF concentrations for various SNP-rs2010963 genotypes (p = 0.0001). A study of VEGF genotype frequency distribution between patients of clinical groups showed a significantly decreased frequency of the genotype G/G (rs2010963) in the IE group with TEC (OR = 0.21; p = 0.014) and increased frequency of G/C (OR = 4.72; p = 0.024) compared with the control group, whereas in patients with IE without TEC, significant ( p = 0.0003) differences in serum concentrations of VEGF-rs2010963 were found in accordance with genotypes GG/CC ( p = 0.01) and GG/GC (p = 0.003). Conclusion. The relationship between the VEGF genotypes (G/G and G/C of rs2010963 polymorphism) and related serum concentration among patients with IE was revealed. Carriers of the minor C allele (rs2010963) had higher serum VEGF levels. The results obtained complement and systematize current scientific data on the disease pathogenesis, as well as focus on the genetic determinant of the developing complications.
引用
收藏
页码:938 / 946
页数:9
相关论文
共 24 条
[1]   Cytokine Signature in Infective Endocarditis [J].
Araujo, Izabella Rodrigues ;
Abreu Ferrari, Teresa Cristina ;
Teixeira-Carvalho, Andrea ;
Campi-Azevedo, Ana Carolina ;
Rodrigues, Luan Vieira ;
Guimaraes Junior, Milton Henriques ;
Souza Barros, Thais Lins ;
Gelape, Claudio Leo ;
Sousa, Giovane Rodrigo ;
Pereira Nunes, Maria Carmo .
PLOS ONE, 2015, 10 (07)
[2]   A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes [J].
Awata, T ;
Inoue, K ;
Kurihara, S ;
Ohkubo, T ;
Watanabe, M ;
Inukai, K ;
Inoue, I ;
Katayama, S .
DIABETES, 2002, 51 (05) :1635-1639
[3]   Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population [J].
Biselli, Patricia Matos ;
Guerzoni, Alexandre Rodrigues ;
de Godoy, Moacir Fernandes ;
Pavarino-Bertelli, Erika Cristina ;
Goloni-Bertollo, Eny Maria .
HEART AND VESSELS, 2008, 23 (06) :371-375
[4]  
Budchanov Y.I., 2010, PRAKTICHESKAYA MEDIT, V6, P19
[5]   Molecular mechanisms and clinical applications of angiogenesis [J].
Carmeliet, Peter ;
Jain, Rakesh K. .
NATURE, 2011, 473 (7347) :298-307
[6]   Vascular Endothelial Growth Factor [J].
Ferrara, Napoleone .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (06) :789-791
[7]  
Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]
[8]   VEGF polymorphisms and severity of atherosclerosis [J].
Howell, WM ;
Ali, S ;
Rose-Zerilli, MJ ;
Ye, S .
JOURNAL OF MEDICAL GENETICS, 2005, 42 (06) :485-490
[9]   Infective Endocarditis: A Contemporary Review [J].
Hubers, Scott A. ;
DeSimone, Daniel C. ;
Gersh, Bernard J. ;
Anavekar, Nandan S. .
MAYO CLINIC PROCEEDINGS, 2020, 95 (05) :982-997
[10]   POLYMORPHISMS IN GENES OF CYTOKINES AND MATRIX METALLOPROTEINASES ASSOCIATED WITH ISCHEMIC HEART DISEASE IN PATIENTS WITH TYPE 2 DIABETES [J].
Klimontov, V. V. ;
Shevchenko, A., V ;
Tyan, N., V ;
Bulumbaeva, D. M. ;
Prokof'ev, V. F. ;
Konenkov, V., I .
KARDIOLOGIYA, 2017, 57 (08) :5-10